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Glomerulonephritis (GN) is a leading cause of end-stage renal disease (ESRD) in Africa.
Data on epidemiology and outcomes of glomerular diseases from Africa is still limited. We
conducted a systematic review on the epidemiology of histologically proven glomerular dis-
eases in Africa between 1980 and 2014.
Materials and methods
We searched literature using PubMed, AfricaWide, the Cumulative Index to Nursing and
Allied Health Literature on EBSCO Host, Scopus, African Journals online databases, and
the African Index Medicus, for relevant studies. The review was conducted using standard
methods and frameworks using only biopsy-confirmed data.
Results
Twenty four (24) studies comprising 12,093 reported biopsies from 13 countries were
included in this analysis. The median number of biopsies per study was 127.0 (50–4436),
most of the studies (70.0%) originated from North Africa and the number of performed kid-
ney biopsies varied from 5.2 to 617 biopsies/year. Nephrotic syndrome was the commonest
indication of renal biopsy. The frequency of reported primary pathologic patterns included,
minimal change disease (MCD); 16.5% (95%CI: 11.2–22.6), focal segmental glomerulo-
sclerosis (FSGS); 15.9% (11.3–21.1), mesangiocapillary GN (MCGN); 11.8% (9.2–14.6),
crescentic GN; 2.0% (0.9–3.5) and IgA nephropathy 2.8% (1.3–4.9). Glomerular diseases
related to hepatitis B and systemic lupus erythematosus had the highest prevalence among
assessed secondary diseases: 8.4% (2.0–18.4) and 7.7% (4.5–11.7) respectively. There
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was no evidence of publication bias and regional differences were seen mostly for second-
ary GNs.
Conclusions
Glomerular diseases remain poorly characterized in sub-Saharan Africa due to declining
renal biopsy rates and consequent paucity of data on pathologic patterns of key renal dis-
eases. Development of renal biopsy registries in Africa is likely to enable adequate charac-
terization of the prevalence and patterns of glomerular diseases; this could have a positive
impact on chronic kidney disease evaluation and treatment in the African continent since
most glomerulopathies are amenable to treatment.
Introduction
End-stage renal disease (ESRD) is a significant public health issue worldwide, and this problem
is compounded by limited access to renal replacement therapy (RRT) in developing countries
[1]. Diabetes mellitus and hypertension are the major causes of ESRD in developed countries
while glomerulonephritis (GN) is reported to overwhelmingly account for a high proportion of
ESRD patients in developing countries [2–5]. The 2012 United States Renal data system
(USRDS) shows that the adjusted ESRD incidence rates by primary cause for diabetes mellitus,
hypertension and GN were 154.1/million/year, 101.1/million/year and 28.3/million/year
respectively [2]. However, data from the Chinese Renal Data System show glomerular diseases
as the most common cause of ESRD (57.4%) [3]. Studies from Africa have shown that glomeru-
lar diseases account for 10.2% to 52% of patients with ESRD [6–11].
The existence of well-established renal registries allows for definition and classification of
the patterns of glomerular diseases in developed countries. For instance, IgA nephropathy is
the commonest GN in Europe, North America and Asia [12]. With few renal registries in
Africa, the patterns of renal diseases are not clearly defined due to limited data stemming from
absence of relevant skills and expertise for performing renal biopsies, or appropriate tools and
infrastructure to process the biopsy data when available. This creates an important gap about
glomerular disease patterns in Africa despite GNs being the commonest cause of ESRD in the
continent. We aimed to systematically review available published literature on the epidemiol-
ogy of histologically proven glomerular diseases in Africa.
Materials and Methods
The review was conducted using the Preferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA) framework [13].
Selection of eligible studies, types of studies and sources of information
Relevant studies were identified by searching PubMed, AfricaWide and the Cumulative Index
to Nursing and Allied Health Literature [CINAHL) on EBSCO Host, Scopus, African Journals
online (AJOL) databases, and the African Index Medicus. The search was limited to studies
from African countries and to articles published between the 1st of January, 1980 and 31st
December, 2014. The search strategy was not restricted to any language. The search was further
enhanced by inspection of bibliographies of articles obtained from the databases search. Two
authors (IGO and OIA) independently conducted the database searches. Abstracts from
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articles in French were assessed by two of the authors (OIA and APK). The reference list of
articles that met the inclusion criteria were inspected for articles relevant to the review. Known
regional experts in glomerular diseases were also contacted for possible additional articles that
might be contained in various regional registries or unindexed local journals.
Search Strategy
The search strategy utilized four main themes to conduct the databases search:
• Theme 1 was related to the disease of interest using Boolean operator “or” and the text-
words that included “glomerulonephritis”, “glomerulonephritides”, “glomerular inflamma-
tion”, and “glomerulosclerosis”.
• Theme 2 was related to the diagnostic method for the disease of interest i.e. “renal biopsy”.
• Theme 3 was related to the population of interest using Boolean operator “or” and the text-
words “child”, “pediatric”, “paediatric”, “adolescents" and “adult”
• Theme 4 was related to the all countries in the region of interest using Boolean operator “or”,
the text-words “Africa”, and each individual country in the region.
Themes 1 to 4 were then combined in sequence with the Boolean operator “AND”. The
search strategy within PUBMED which had returned the highest results is depicted in (S1
Table).
Data Collection
Two authors (IGO and OIA) independently assessed all abstracts for eligibility. In situations of
disagreements between the two reviewers, a third reviewer (APK) arbitrated for eligibility. The
inclusion criteria was that a study had to: 1) be conducted amongst African populations resid-
ing in Africa; 2) report on only biopsy-proven cases of GN; 3) enrolled at least 50 participants;
4)provided data on the demographic distribution and histopathologic types of the reported
GN. We excluded studies whose focus was on: transplant related GNs, in Africans residing on
other continents, entire cohort had a single or specific histopathologic type of GN, a clinical
syndrome of GN without renal biopsy, and GNs reported in autopsy samples. Fig 1 shows the
PRISMA study selection flowchart. A full text review of selected studies was then conducted to
extract relevant data. Data collected included: year of publication, country and African region
of publication, study design, number of biopsies performed, age at biopsy, gender distribution,
indications for biopsy and the frequencies of reported glomerular diseases.
Data Extraction and synthesis
The studies were categorized into 3 groups (A, B or C) depending on whether the reporting
was for adults only, combined adult and paediatric study or paediatric study only, respectively.
The characteristics of the selected articles extracted include the main indication for renal
biopsy, age of patients at the time of biopsy, the period over which the biopsies had been done,
and the number of biopsies performed in the period. The average number of biopsies per-
formed per study was calculated as the total number of biopsies over the entire period divided
by the total duration of the study. The frequencies of primary and secondary GNs were deter-
mined. Secondary GNs selected for reporting were limited to lupus nephritis (LN), GNs related
to human immunodeficiency virus (HIV) and hepatitis B viral infections and amyloidosis as
these were the commonly reported forms of secondary GNs. Data extraction was done by one
author (IGO) and another author (OIA) verified the accuracy and validity of extracted data. To
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generate the frequency of different GNs across studies, the DerSimonian-Laird random effects
models were used to pool study level estimates overall and by geographic region [North Africa,
East and Central Africa, Southern Africa, and West Africa]. To minimise the effect of extreme
proportions on the overall estimates, we first stabilized the variance of the raw prevalence with
a single arcsine transformation before pooling [14]. Heterogeneity across studies was assessed
with the use of the Cochran Q and I2 statistics [15], while the Egger test of bias [16] was used to
investigate the publication bias. All analyses used the R statistical software (version 3.0.3 [2014-
03-06], The R Foundation for statistical computing, Vienna, Austria) and ‘meta’ package (ver-
sion 4.1–0).
Results
Demographic and clinical features
Twenty-four full papers were reviewed and analysed for this study [17–40]. Eight of the 24
studies (33.3%) reported on studies in adults (group A) [17–24], 11/24 (45.8%) comprised
adults and paediatrics (group B) [25–35] and 5/24 studies (20.8%) were restricted to paediatric
age groups (group C) [36–40]. Overall, 12,093 renal biopsies were reported in the 35 year
period evaluated. The period of analysis ranged from as short as 12 months to up to 30 years
and only 3 studies were found to have had a prospective design; no study was reported from a
national renal biopsy registry. Most of the studies in all the groups had a male predominance:
45.2%–62.7% for studies in group A; 47.3%–64.3% for studies in group B and 53.0%–68.8% for
studies in group C. The average age at time of biopsy for the studies in group A was less than
40 years, while group C studies had an average age less than 9.5 years. Overall, the median
number of biopsies per study was 127.0 (50–4436), however, the rate of renal biopsies reported
per year showed extensive variation (group A: 17.1/year to 134/year; group B: 7.9/year to 617/
Fig 1. PRISMA flow diagram of study selection.
doi:10.1371/journal.pone.0152203.g001
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year and group C: 5.2/year to 83.1/year). Nephrotic syndrome was the most common indica-
tion for renal biopsy and in 11/24 studies (45.8%), nephrotic syndrome was the sole reason
(100%) for performing a biopsy [18–20, 25–29, 34, 36–38] (Table 1). Overall, 11/24 studies
(45.8%) were published from the year 2000 onwards with 8 from North Africa, 2 fromWest
Africa and 1 from Southern Africa [21–24, 31–35, 39, 40]. Eight studies did not use the special
stains (immunofluorescence or immunohistochemistry or immunoperoxidase) for evaluation
of renal histology [17, 19, 20, 25, 26, 28, 29, 35]. Two studies reported that the special stains
were performed in Europe (UK and France) [30, 32].
Distribution of glomerular disease patterns
Table 2 shows regional differences of types of GN as reported from the various studies. The
proportion of biopsies performed for the search period per region was 70.0%, 16.1%, 7.9% and
5.9% for North Africa, Southern Africa, West Africa and East and Central Africa respectively.
With the exception of diffuse proliferative GN (DPGN) (p = 0.0005), the contribution of pri-
mary aetiologies to the distribution of GNs across regions was mostly similar (all p0.099 for
regional differences). With regard to secondary GNs, significant regional differences were
apparent (all p<0.052), although some comparisons were based on very few outcomes. For
both primary and secondary GNs, there was indication of significant within region heterogene-
ities for some of the outcomes. But within region heterogeneities have to be interpreted against
the background of small number of eligible studies within regions.
The prevalence of the various GNs according to countries and age at time of diagnosis is
summarized in Figs 2 and 3 and in S1–S5 Figs. The overall prevalence of minimal change dis-
ease (MCD) was the highest of all GNs reported by all 24 studies at 16.5% (95%CI: 11.2–22.6;
n = 7657; p-heterogeneity<0.0001). The highest prevalence of MCD was from a group B study
in Morocco: 79.2% (68.5–87.6) [34] while 2 studies from Nigeria reported the lowest preva-
lence [17, 28]. Paediatric studies (group C) had the highest prevalence of MCD (compared to
group A and B) but there was no significant difference across age groups (p = 0.496) (Fig 2A).
There was no significant regional difference in overall prevalence of MCD in Africa (p = 0.406)
although North Africa and East and Central African countries had the highest prevalence of
MCD (Table 2).
The overall prevalence of focal segmental glomerulosclerosis (FSGS) pattern was 15.9%
(11.3–21.1; p-heterogeneity <0.0001) (Fig 2B). Two studies from Senegal reported the highest
prevalence rates: 51.9% (45.7–58.2) [21] and 47.0 (37.6–56.5) [32]. Awunnor-Renner et al [17]
reported the lowest prevalence from adults in Zaria, Nigeria: 0.7% (0.0–4.1) while the lowest
prevalence in paediatric studies was also reported from another study from Zaria, Nigeria [36].
However, other studies from Nigeria reported prevalence rates as high as 27.3% [20]. The prev-
alence of FSGS according to regions was highest for West Africa: 19.1% (5.9–37.4) and lowest
for North Africa: 13.2% (9.5–17.5) but without significant interregional differences (p = 0.889)
(Table 2).
The prevalence of other reported primary GN patterns were: 9.2% (95%CI: 6.2–12.7; p-het-
erogeneity<0.0001, difference across age groups: p = 0.511) for mesangial proliferative GN
(MesPGN), 11.8% (95%CI: 9.2–14.6; p-heterogeneity <0.0001, difference across age groups:
p = 0.435) for mesangiocapillary GN (MCGN), 6.6% (95%CI: 4.6–9.0; p-heterogeneity
<0.0001, difference across age groups: p = 0.0001) for membranous GN (MGN), 2.8% (95%CI:
1.3–4.9; p-heterogeneity <0.0001, differences across age groups: p = 0.0039) for IgA nephropa-
thy (IgAN), 3.5% (95%CI: 0.2–10.9; p-heterogeneity<0.0001, differences across age groups:
p = 0.467) for post-infectious GN (PIGN), 2.0% (95%CI: 0.9–3.5; p-heterogeneity<0.0001, dif-
ferences across age groups: p = 0.862) for crescentic GN, 10.7% (95%CI: 6.8–15.3; p-
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Table 2. Frequencies of glomerular diseases by African regions.
GN Type Regions N studies N biopsies N outcomes % (95% CI) I2 P heterogeneity p-diff Regions
MCD ECAf 4 714 139 20.6 (15.0–26.8) 66.3 0.031 0.406
NAf 7 4034 612 22.5 (12.6–34.3) 98.4 <0.0001
SAf 4 1951 211 11.2 (0.3–34.5) 99.1 <0.0001
WAf 8 958 127 12.2 (4.4–23.1) 95.0 <0.0001
MesPGN ECAf 2 472 109 14.7 (1.5–38.1) 92.7 0.0002 0.771
NAf 5 2711 249 7.0 (4.0–10.8) 89.2 <0.0001
SAf 3 1832 127 8.9 (4.9–14.1) 87 0.0005
WAf 3 287 29 9.5 (1.5–23.3) 90.6 <0.0001
MCGN ECAf 4 714 65 9.1 (7.1–11.3) 0 0.822 0.087
NAf 7 8393 785 9.7 (6.6–13.4) 95.1 <0.0001
SAf 4 1951 130 6.4 (3.8–9.6) 75.8 0.006
WAf 7 843 161 20.7 (8.9–35.7) 95.8 <0.0001
FSGS ECAf 4 714 118 15.5 (5.7–29.0) 93.4 <0.0001 0.889
NAf 7 4034 543 13.2 (9.5–17.5) 91.4 <0.0001
SAf 4 1951 212 14.5 (2.8–33.2) 98.5 <0.0001
WAf 8 958 265 19.1 (5.9–37.4) 97.6 <0.0001
MGN ECAf 4 714 74 12.5 (7.1–19.2) 78.3 0.0032 0.142
NAf 8 8470 649 5.7 (2.2–10.5) 98.1 <0.0001
SAf 4 1951 127 5.7 (2.1–9.9) 89.4 <0.0001
WAf 8 958 70 5.9 (3.0–9.6) 78.1 <0.0001
IgAN ECAf 1 50 0 0.0 (0.0–1.9) - - 0.099
NAf 6 7469 332 3.8 (1.6–6.9) 96 <0.0001
SAf 1 1284 26 2.0 (1.3–2.9) - -
WAf 1 115 2 1.7 (0.2–4.9) - -
PIGN ECAf 1 50 0 0.0 (0.0–1.9) - - 0.102
NAf 2 482 81 10.3 (0.0–41.3) 98.4 <0.0001
SAf 2 1352 38 2.8 (2.0–3.7) 0 0.431
WAf 1 115 3 2.6 (0.5–6.3) - -
CresGN ECAf 3 622 41 3.9 (0.6–10.0) 85.2 0.0012 0.565
NAf 3 2641 32 1.4 (0.5–27.4) 80.2 0.0064
SAf 2 1403 52 2.4 (0.2–6.6) 80.6 0.023
WAf 4 467 7 1.1 (0.05–3.4) 68.7 0.023
DPGN ECAf 4 714 82 10.3 (4.1–18.8) 88 <0.0001 0.0005
NAf 5 8001 602 4.6 (1.1–10.2) 98.7 <0.0001
SAf 1 119 28 23.5 (16.4–31.5) - -
WAf 5 497 98 17.8 (9.1-28-7) 88.2 <0.0001
FPGN ECAf 1 422 6 1.4 (0.5–2.8) - - 0.134
NAf 3 3404 251 6.5 (2.1–13.2) 97.8 <0.0001
SAf 1 119 4 3.4 (0.9–7.3) - -
WAf 4 399 13 2.3 (0.1–7.2) 82.9 0.0006
Lupus Nephritis ECAf 1 422 6 1.4 (0.5–2.8) - - <0.0001
NAf 6 8322 1122 13.9 (8.9–19.9) 97.6 <0.0001
SAf 3 1471 254 6.1 (0.0–22.5) 96.8 <0.0001
WAf 4 554 19 3.0 (0.1–9.8) 90.6 <0.0001
Hep B ECAf 1 422 0 0.0 (0.0–0.2) - - <0.0001
NAf 1 321 10 3.1 (1.5–5.3) - -
SAf 3 1832 116 14.5 (0.7–41.2) 99.1 <0.0001
(Continued)
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heterogeneity<0.0001, differences across age groups: p = 0.096) for DPGN and 3.6% (95%CI:
1.4–6.8; p-heterogeneity <0.0001, differences across age groups: p<0.0001) for focal prolifer-
ative GN (FPGN). Only 4 primary disease patterns (MCD, MCGN, FSGS and MGN) were
reported from more than 20 of the 24 studies. There was no evidence of publication bias across
all studies on primary GNs, all p0.143 for the Egger test of bias (S1–S4 Figs).
Table 2. (Continued)
GN Type Regions N studies N biopsies N outcomes % (95% CI) I2 P heterogeneity p-diff Regions
WAf 3 352 53 11.0 (0.0–39.4) 97.6 <0.0001
HIVAN ECAf None - - - - - 0.233
NAf 1 321 0 0.0 (0.0–0.3 - -
SAf 2 1764 145 2.9 (0.0–23.6) 99.4 <0.0001
WAf 1 258 1 0.4 (0.0–1.5) - -
Amyloid ECAf 3 664 15 3.0 (0.2–6.7) 88 0.0002 0.052
NAf 6 8078 559 4.3 (1.4–8.6) 97.9 <0.0001
SAf 2 1403 16 1.1 (0.6–1.8) 0 0.596
WAf 6 772 18 2.2 (1.3–3.4) 0 0.638
MCD–Minimal change disease; MesPGN–Mesangial proliferative GN, MCGN–Mesangiocapillary GN; FSGS–Focal segmental glomerulosclerosis; MGN–
Membranous GN; IgAN–Ig A nephropathy; PIGN–Post-infectious GN; CresGN–Crescentic GN; DPGN–Diffuse proliferative GN; FPGN–Focal proliferative
GN; Hep. B–Hepatitis B; HIVAN–Human immunodeficiency virus associated nephropathy, WAf–West Africa, ECAf–East and Central Africa, SAf–Southern
Africa, NAf–North Africa.
doi:10.1371/journal.pone.0152203.t002
Fig 2. Forest plot for random-effects meta-analyses for MCD and FSGS. This figure shows the pooled prevalence of minimal change disease (2A) and
focal segmental glomerulosclerosis (2B) overall and by age group (MCD–minimal change disease, FSGS–focal segmental glomerulosclerosis).
doi:10.1371/journal.pone.0152203.g002
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Glomerular diseases related to hepatitis B virus infection had the highest prevalence among
the reported secondary GNs: 8.4% (95% CI: 2.0–18.4; p-heterogeneity <0.0001, differences
across age groups: p<0.0001) (Fig 3A). Lupus nephritis (LN) had the second highest preva-
lence: 7.7% (95%CI: 4.5–11.7; p-heterogeneity <0.0001, differences across age groups:
p<0.0001) (Fig 3B). The high prevalence of LN was due to the high prevalence from studies
from North Africa (p for difference across regions<0.0001). Surprisingly, the human immu-
nodeficiency virus associated nephropathy (HIVAN) had an overall prevalence of 1.0% (95%:
0.0–9.0; p-heterogeneity<0.0001, differences across age groups: p<0.0001). Amyloid was pres-
ent in 2.9%. There was no evidence of publication bias, all p0.082 for the Egger test of bias
(Fig 3, S5A and S5B Fig). Fig 4A and 4B shows the crude prevalence of primary and secondary
Fig 3. Forest plot for random-effects meta-analyses for hepatitis B related GNs and lupus nephritis. This figure shows the pooled prevalence of
hepatitis B related GNs (3A) and lupus nephritis (3B) overall and by age group.
doi:10.1371/journal.pone.0152203.g003
Fig 4. Regional differences (North Africa vs sub-Saharan Africa) in the prevalence of GNs. This figure
shows the regional differences in the prevalence of primary GNs (4A) and secondary GNs (4B) for North
Africa and sub-Saharan Africa.
doi:10.1371/journal.pone.0152203.g004
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GNs in North Africa and sub-Saharan Africa (SSA) with MCGN as the commonest primary
GN in North Africa (9.3%) while FSGS is the most common in SSA (16.4%). Of the secondary
GNs, LN was more common in North Africa while all reported HIVAN was from SSA.
Discussion
There is paucity of reliable data on the epidemiology of ESRD in many parts of Africa partly
due to the unavailability of renal registries. In Africa, glomerular diseases have been reported to
account for a large proportion of patients with ESRD from several studies (reviewed in Maou-
joud et al) [5]; in many of such studies, the diagnosis of GN may have been assumed given that
late presentation of patients is common in Africa. In this review, we have found that: (i) most
renal biopsies reported from Africa originates from studies in North Africa, (ii) MCD, FSGS
and MCGN are the most common patterns of glomerular diseases reported in Africa, (iii) Hep-
atitis B and LN are common and important secondary causes of GNs and (iv) lack of standard
and consistency in reporting renal biopsies.
Of the 12,093 biopsies that were reported, 70% were from studies carried out in North
Africa and these countries had more papers published after the year 2000 compared to coun-
tries from sub-Sahara Africa. Due to cost (out-of-pocket payment), absence of skills for per-
forming biopsies, handling of tissue and adequate interpretation of histology few centres in
Africa are able to regularly perform renal biopsies (IGO, one of the co-authors can personally
confirm this from meetings as an ISN educational ambassador in Africa).
Overall, MCD, FSGS and MCGN patterns of glomerular diseases were the most frequently
reported GNs. This may be because in 11 of the 24 studies, nephrotic syndrome was the sole
indication for performing a renal biopsy [18–20, 26–29, 34, 36–38] and these conditions are
common causes of nephrotic syndrome. We observed that only six studies [17, 22–24, 34, 40]
differentiated the glomerular disease patterns into primary and secondary causes. Hence, the
proportion of the reported diagnoses/patterns that were truly of primary cause is unclear. For
instance, although a number of studies in this review showed that MCGN is common, recent
reports [41] have proven the rarity of true primary MCGN if appropriate diagnostic algorithms
were applied. However, one study from South Africa reported primary MCGN to be common
after an exhaustive search for secondary causes and also reported poor prognostic factors asso-
ciated with MCGN [42]. We think that the high prevalence of FSGS may be related to a limited
evaluation for secondary causes. A key study by Van Rensburg et al from Bloemfontein South
Africa found FSGS to be the most common histological diagnosis in a 10 year review of medical
renal diseases [43], but they reported that all FSGS (including HIV) were grouped together.
The role of genetic factors such as the APOL-1 which have been shown to be strongly associ-
ated with FSGS (either primary or secondary association with HIV) in Africans [44, 45] sup-
ports our observation of an increased prevalence of FSGS in Africa.
Sub-Sahara Africa has the highest prevalence of hepatitis B virus infection in comparison to
other regions in the world [46], hence this may account for the high prevalence of GNs related
to hepatitis B infection. Glomerular diseases associated with hepatitis B were common in chil-
dren fromWest and Southern Africa [36–38]. We speculate that the observed prevalence may
be much lower than true prevalence due to under-reporting of cases. However, the studies [17,
18, 22, 29, 36–39] that reported GNs in hepatitis B positive patients did not show direct evi-
dence for viral particles in the glomerulus. The result of the meta-analysis done for secondary
GNs is perhaps related to the low performance and reporting of renal biopsies. Further, sub-
Saharan Africa still bears an inordinate share of the global HIV burden. In 2014, that number
reached 25.8 million [24.0 million –28.7 million], 70% of the global burden of HIV [47]. Given
the very high HIV burden in SSA, HIVAN would be expected to be the secondary GN with the
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highest prevalence. However, this was not the case partly due to underperformance and report-
ing of renal biopsies across Africa. We have previously reported a rising incidence in biopsies
associated with HIV in Cape Town from 6.6% in 2000 to 25.7% in 2009 [22] and this trend
may apply to other countries with a high burden of HIV. Also, many studies from Africa
describe renal disease in HIV positive patients without performing a renal biopsy. For example,
Emem et al from Nigeria described the prevalence, clinical features and risk factors of renal dis-
ease in 400 consecutive HIV/AIDS patients presenting to their centre. However, only 10
patients had a renal biopsy out of which 7 (70%) had FSGS and the histology in others were
reported as normal [48].
Similarly, LN is increasingly diagnosed in Africans especially from South Africa and coun-
tries of North Africa. The study from Tunisia clearly showed a changing pattern in the epide-
miology GN over time and suggested that improving socio-economic factors might have
played a role in the increasing prevalence of LN and IgA nephropathy while conditions often
associated with chronic infections (e.g. MCGN and Amyloidosis) had reduced within three
decades [33]. A disease entity we did not find reported during the assessed period was “malaria
nephropathy” which used to be commonly reported from studies in the 60s and 70s [49, 50].
Whether this is related to improving socio-demographic factors or better and clearer diagnostic
methods is not known. However, a number of authors have recently disputed the evidence for
malarial nephropathy [51, 52].
We acknowledge key limitations of this work including lack of immunofluorescence tech-
nology in most of the studies and the absence of uniformity in describing pathologic patterns.
For instance, most studies published before the year 2000 often referred to diffuse proliferative
and focal proliferative GNs without further elaboration of the pattern (e.g. crescentic, necrotiz-
ing lesions or vasculitis). As many of the studies did not say if further serological, immunohis-
tochemistry or immunofluorescence tests were conducted, some of the reported cases of
DPGN / FPGN may have fallen under categories such as crescentic GN or PIGN.
Further, the small number of studies and studies with limited samples precluded careful
investigation of the substantial heterogeneities observed across studies by subgroup and meta-
regression analyses. It is known, however that statistical approaches to assessing heterogeneity
could yield spurious results within uncontrolled studies. Hence, given that many of the studies
included in this review were inherently weak, caution must be exercised in the interpretation of
the results especially with regard to the prevalence of HIVAN as observed and reported.
Although this is a weakness of this study, we are however confident that the results present a
perspective of GN types commonly encountered in Africa. Although the performance of renal
biopsies is necessary for diagnosis of GNs, we also acknowledge that this is not feasible in most
African countries where the facilities and expertise are limited. There is therefore an urgent
need to support initiatives (such as the ISN’s educational ambassador program) to improve the
expertise in renal biopsy performance, tissue processing and interpretation especially in SSA
where this skill is typically absent. By doing this, renal biopsy registries are likely to become
developed in Africa. This is not impossible despite the numerous challenges and will enhance
our understanding of the epidemiology of GNs in Africa.
In conclusion, GNs in Africa are poorly characterized, especially in sub-Saharan Africa
where the number of diagnostic biopsies performed has continued to decline over the last
decade. Understanding the epidemiology of GNs in Africa is vital for an optimal care of
patients with such conditions that are frequently associated with ESRD in this region. This
could impact positively on CKDmanagement in Africa as GNs are amenable to treatment in
instances where they are diagnosed early enough. There is need to develop initiatives that assist
in improving the expertise in renal biopsy performance, tissue processing and interpretation in
Africa.
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